title: Adenovirus infection results in alterations of insulin signaling and glucose homeostasis.
abstract: Recombinant adenovirus (Ad) vectors can initiate an inflammatory response, limiting its use in gene therapy and basic research. Despite increased efforts to better understand Ad infection, little is known about how it affects cellular metabolic responses. In the current studies, we explored the effects of Ad vectors on insulin signaling molecules and glucose homeostasis. Nonreplicative Ad vectors were injected into rats through the tail vein, and at 4-13 days postinjection insulin signaling and glucose tolerance were examined. Ad vector infection significantly reduced total levels of the insulin receptor (IR), and insulin receptor substrates 1 and 2 (IRS-1, IRS-2) in the liver of rats, resulting in decreased insulin-induced tyrosine phosphorylation of IR, IRS-1, and IRS-2, and decreased interaction of IRS-1 and IRS-2 with phosphoinositide 3-kinase (PI3K). In addition, Ad infection resulted in impaired systemic glucose homeostasis, which recovered by 13 days, after the protein levels of IR, IRS-1, and IRS-2 had started to normalize. Expression of a TNF inhibitor or Kupffer cell depletion attenuated the Ad vector-induced decreases of insulin signaling molecules, indicating a potential role of Kupffer cell activation in this process. These studies provide evidence that systemic administration of Ad vectors can impair insulin signaling in liver, resulting in altered systemic glucose metabolism. Thus, effects of Ad vector infection on insulin action and glucose metabolism need to be considered when Ad vectors are used in research or gene therapy and may be more broadly applicable to other viral agents.
authors.affiliation: Department of Pathology, Division of Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA.
authors.forename: Shaoning
authors.initials: S
authors.lastname: Jiang
authors.forename: Tatyana A
authors.initials: TA
authors.lastname: Gavrikova
authors.forename: Alexander
authors.initials: A
authors.lastname: Pereboev
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Messina
mesh_terms: D000256:Adenoviridae / Q000378:metabolism*; D000257:Adenoviridae Infections / Q000378:metabolism* / Q000821:virology; D000818:Animals; D015153:Blotting, Western; D005822:Genetic Vectors; D005947:Glucose / Q000378:metabolism*; D005951:Glucose Tolerance Test; D007150:Immunohistochemistry; D007328:Insulin / Q000378:metabolism*; D055504:Insulin Receptor Substrate Proteins / Q000378:metabolism; D007728:Kupffer Cells; D008099:Liver / Q000201:enzymology / Q000378:metabolism / Q000821:virology; D008297:Male; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011972:Receptor, Insulin / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D007328:Insulin; D055504:Insulin Receptor Substrate Proteins; C526296:Irs1 protein, rat; D014409:Tumor Necrosis Factor-alpha; D019869:Phosphatidylinositol 3-Kinases; D011972:Receptor, Insulin; D005947:Glucose
references.citation: J Virol. 1997 Jan;71(1):624-9
references.pmid: 8985392
references.citation: Hepatology. 2003 Dec;38(6):1384-92
references.pmid: 14647049
references.citation: Nat Rev Genet. 2003 May;4(5):346-58
references.pmid: 12728277
references.citation: J Virol. 1997 Nov;71(11):8798-807
references.pmid: 9343240
references.citation: Hepatology. 2008 Jun;47(6):2127-33
references.pmid: 18446789
references.citation: Curr Opin Mol Ther. 2008 Oct;10(5):439-48
references.pmid: 18830919
references.citation: J Leukoc Biol. 1992 Sep;52(3):296-302
references.pmid: 1522388
references.citation: Diabetes. 2003 Sep;52(9):2239-48
references.pmid: 12941762
references.citation: Hum Gene Ther. 2004 Dec;15(12):1157-66
references.pmid: 15684693
references.citation: Am J Pathol. 2004 Nov;165(5):1499-508
references.pmid: 15509521
references.citation: Mol Ther. 2001 May;3(5 Pt 1):697-707
references.pmid: 11356075
references.citation: Science. 1996 Feb 2;271(5249):665-8
references.pmid: 8571133
references.citation: Hum Gene Ther. 1999 Apr 10;10(6):965-76
references.pmid: 10223730
references.citation: Am J Gastroenterol. 2009 Jan;104(1):76-82
references.pmid: 19098853
references.citation: Acta Physiol (Oxf). 2008 Jan;192(1):29-36
references.pmid: 18171427
references.citation: J Gastroenterol Hepatol. 2008 May;23(5):779-82
references.pmid: 18028349
references.citation: FEBS Lett. 2008 Jan 9;582(1):97-105
references.pmid: 18053812
references.citation: Endocrinology. 2004 Nov;145(11):5168-76
references.pmid: 15297437
references.citation: Science. 1999 Dec 17;286(5448):2244-5
references.pmid: 10636774
references.citation: Trends Endocrinol Metab. 2006 Mar;17(2):72-8
references.pmid: 16458527
references.citation: Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):215-9
references.pmid: 8278368
references.citation: J Biol Chem. 2008 Dec 19;283(51):35375-82
references.pmid: 18952604
references.citation: Int J Obes (Lond). 2005 Jun;29(6):603-6
references.pmid: 15738934
references.citation: Intern Emerg Med. 2008 Jun;3(2):99-108
references.pmid: 18274709
references.citation: J Cell Sci. 2006 Sep 15;119(Pt 18):3788-98
references.pmid: 16940353
references.citation: N Engl J Med. 1996 May 2;334(18):1185-7
references.pmid: 8602187
references.citation: Endocrinology. 2009 Jan;150(1):24-32
references.pmid: 18801909
references.citation: Gene Ther. 2000 Jun;7(12):1034-8
references.pmid: 10871752
references.citation: Endocrinology. 1998 Dec;139(12):4928-35
references.pmid: 9832430
references.citation: Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1200-5
references.pmid: 9037030
references.citation: Nat Rev Mol Cell Biol. 2006 Feb;7(2):85-96
references.pmid: 16493415
references.citation: Oncologist. 2002;7(1):46-59
references.pmid: 11854546
references.citation: J Biol Chem. 2002 Nov 1;277(44):42394-8
references.pmid: 12228220
references.citation: Am J Physiol Gastrointest Liver Physiol. 2003 Jan;284(1):G107-15
references.pmid: 12388175
references.citation: J Nutr. 2001 Oct;131(10):2794S-2797S
references.pmid: 11584109
references.citation: Am J Gastroenterol. 2003 Dec;98(12):2751-6
references.pmid: 14687828
references.citation: J Gen Virol. 1997 Jul;78 ( Pt 7):1527-31
references.pmid: 9225025
references.citation: Hum Gene Ther. 2003 May 1;14(7):627-43
references.pmid: 12804145
references.citation: Mol Cell. 2000 Jul;6(1):87-97
references.pmid: 10949030
references.citation: J Biol Chem. 2004 Oct 29;279(44):45803-9
references.pmid: 15331609
references.citation: Int J Obes Relat Metab Disord. 2003 Dec;27 Suppl 3:S46-8
references.pmid: 14704744
references.citation: Gene Ther. 2003 Jun;10(11):935-40
references.pmid: 12756413
references.citation: Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E581-91
references.pmid: 18728222
references.citation: Endocrinology. 2008 May;149(5):2369-82
references.pmid: 18187553
references.citation: J Virol. 2004 May;78(10):5368-81
references.pmid: 15113916
references.citation: Hum Gene Ther. 2003 Nov 20;14(17):1631-41
references.pmid: 14633405
references.citation: Endocrinology. 2007 Jun;148(6):2994-3003
references.pmid: 17379643
references.citation: Am J Physiol Endocrinol Metab. 2002 Sep;283(3):E413-22
references.pmid: 12169433